Concepedia

Simultaneous Population Pharmacokinetic Model for Lopinavir and Ritonavir in HIV-Infected Adults

José Moltó, Manuel José Barbanoj, Cristina Miranda, Asunción Blanco, José Ramón Santos, Eugènia Negredo, Peré Domingo, Bonaventura Clotet, Marta Valle

Clinical Pharmacokinetics · 2008 · 47 citations · 35 references

DOI

Concepts

References

35

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Richard K. Sterling, Eduardo Lissen, Nathan Clumeck et al. · Hepatology · 2006 · 4.8K citations · Full text

, , +17

Some suggestions for measuring predictive performance

Lewis B. Sheiner, Stuart L. Beal · Journal of Pharmacokinetics and Biopharmaceutics · 1981 · 1.6K citations

, , +8

Xpose—an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

E. Niclas Jonsson, Mats O. Karlsson · Computer Methods and Programs in Biomedicine · 1998 · 1K citations

, , +12

ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease

Hing L. Sham, Dale J. Kempf, Akhteruzammen Molla et al. · Antimicrobial Agents and Chemotherapy · 1998 · 470 citations · Full text

, , +16

The Tablet Formulation of Lopinavir/Ritonavir Provides Similar Bioavailability to the Soft-Gelatin Capsule Formulation With Less Pharmacokinetic Variability and Diminished Food Effect

Cheri E. Klein, Yi‐Lin Chiu, Walid M. Awni et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 153 citations

, , +17